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We utilized the budding yeast Saccharomyces cerevisiae as a model to systematically explore physiological roles for yeast and mammalian
aldo-keto reductases. Six open reading frames encoding putative aldo-keto reductases were identified when the yeast genome was queried against
the sequence for human aldose reductase, the prototypical mammalian aldo-keto reductase. Recombinant proteins produced from five of these
yeast open reading frames demonstrated NADPH-dependent reductase activity with a variety of aldehyde and ketone substrates. A triple aldo-keto
reductase null mutant strain demonstrated a glucose-dependent heat shock phenotype which could be rescued by ectopic expression of human
aldose reductase. Catalytically-inactive mutants of human or yeast aldo-keto reductases failed to effect a rescue of the heat shock phenotype,
suggesting that the phenotype results from either an accumulation of one or more unmetabolized aldo-keto reductase substrates or a synthetic
deficiency of aldo-keto reductase products generated in response to heat shock stress. These results suggest that multiple aldo-keto reductases
fulfill functionally redundant roles in the stress response in yeast.
© 2006 Elsevier B.V. All rights reserved.Keywords: Aldo-keto reductase; Aldose reductase; Saccharomyces cerevisiae; Mutagenesis; Heat shock1. Introduction
Aldo-keto reductases (AKR)1 comprise a superfamily of
structurally-similar proteins that catalyze the NADPH-depen-
dent conversion of various carbonyl compounds into their
corresponding alcohol products. In humans, the AKRs are
implicated in diseases involving disposition of excess aldoses.
Aldose reductase (AR), a prototypical AKR, catalyzes the
conversion of glucose into sorbitol, which represents the first
step in the polyol pathway. In humans with diabetes mellitus,
increased activity of the polyol pathway due to chronic
hyperglycemia has been associated with complications such asAbbreviations: AKR, aldo-keto reductase; AR, aldose reductase; GPD,
glyceraldehyde 3-phosphate dehydrogenase; IEC, ion exchange chromatogra-
phy; ORF, open reading frame; YPD, yeast peptone dextrose; synthetic
complete
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[3]. Beneficial roles for AKRs have been difficult to establish
because tissues typically contain many similar enzymes with
overlapping substrate and inhibitor specificities. Genetics-based
approaches to explore physiological function using the mouse
model have also been inconclusive, primarily due to probable
redundancies between aldose reductase and similar aldo-keto
reductases such as MVDP [major vas deferens protein, ref. [4]]
and FR-1 [fibroblast growth factor regulated-1, ref. [5]].
Disruption of the aldose reductase gene in mice demonstrate a
relatively benign phenotype resembling that of diabetes
insipidis, which may be related to altered osmotic regulation in
the kidneys of mutant animals [6,7].
The purpose of the current study was to utilize a simpler and
more manageable eukaryotic model system to explore AKR gene
function. By BLAST analysis of the Saccharomyces cerevisiae
genome, we previously identified six open reading frames
(YHR104W, YOR120W, YDR368W, YBR149W, YJR096W,
YDL124W) which encode proteins with high predicted sequence
similarity to human aldose reductase [8]. Three of these ORFs
(YHR104W, YDR368W, YOR120W) have been previously
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dependent carbonyl reductases [9–11], whereas one (YBR149W)
functions primarily in the direction of alcohol (arabinose)
oxidation [12]. In preliminary studies, we previously demon-
strated that a triple null strain produced by disruption of ORFs
encoding the three known AKRs exhibits a heat shock phenotype
[13]. In the current study, we sought to evaluate the remaining two
ORFs identified in our BLAST analysis (YJR096W and
YDR368W) with respect to the kinetic properties of their encoded
proteins as well as to probe for phenotypes of a mutant strain
deficient in the five targeted aldo-keto reductases.
2. Materials and methods
2.1. Expression and purification of recombinant yeast AKRs
Slightly different methods were used for production of recombinant yeast
AKRs. The ORF for YJR096W (AKR5F), obtained from The Institute for
Genome Research (TIGR, Rockville, MD), was subcloned into the prokaryotic
expression plasmid pET23D (Novagen, Madison, WI) for expression of the
recombinant protein in Escherichia coli strain BL21. The ORFs for YDL124W
(AKR5G) and YOR120W (AKR3A1), obtained by PCR amplification from
genomic DNA purified from S. cerevisiae strain S288c, were cloned into
pET16B and pET23D (Novagen), respectively. Coding sequences in all
plasmids were confirmed against the genome sequence of wild type S.
cerevisiae strain S288c [14] prior to expression studies.
Recombinant proteins were purified from cultures grown in baffled shake
flasks. In all cases, log phase cultures were grown for 4–16 h following
treatment with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) to induce
expression of recombinant proteins. Cells were harvested by centrifugation
(15,000×g, 15 min, 4 °C) and were lysed after treatment with DNase (Sigma, St.
Louis, MO) and lysozyme as described previously [15]. Extraction buffers
contained the protease inhibitors (each at 1 μg/ml) antipain, bestatin,
chymotrypsin, leupeptin, and pepstatin (Roche, Indianapolis, IN).
All extraction and purification steps were carried out at 4 °C. As a group,
yeast AKRs were readily prepared as recombinant proteins in E. coli host
cultures. All except AKR5G (Ydl124w) were recovered as buffer-soluble
proteins following extraction from host cells. In preliminary studies of AKR5G,
expression of the encoded protein with an amino terminal histidine tag (7
residues in length) was associated with poor aldo-keto reductase activity [8]. For
this reason, all yeast AKRs used in this study were expressed without fusion
with affinity epitopes.
Methods and conditions for purification of each of the individual
recombinant yeast AKRs are given below. In all cases, our methods routinely
yielded in excess of 30 mg of highly purified protein from each liter of culture.
2.2. AKR3A1 (Yor120w)
Initial purification of AKR3A1 from host cell lysates was achieved by IEC
using a carboxymethyl exchange resin (Macro-Prep CM, Bio-Rad). Lysate material
from host cultures was first extensively dialyzed against a solution of 20 mM (2-
[N-morpholinoethanesulfonic acid, MES), pH 6.0, containing 1 mM each of DTT
and EDTA. After a brief centrifugation to remove insoluble materials, the dialyzed
lysate was applied at 1 ml/min to a 2.5×10 cm column packed with the Macro-
Prep CM resin. Unadsorbed material was flushed from the column with
approximately 80 ml loading buffer. Bound materials were then eluted with a
linear gradient of NaCl (0–0.5 M), contained in the loading buffer, over a volume
of 600 ml. The eluate was continuously monitored by absorbance at 280 nm and
was collected into 10 ml fractions for measurement of NADPH-dependent
reductase activity using 5 mM DL-glyceraldehyde as substrate. Column fractions
with reductase activity were pooled and dialyzed against 10 mM potassium
phosphate buffer, pH 7.0, containing 1 mM DTT and 1 mM EDTA. AKR3A1 was
further purified by dye-affinity chromatography using Affi-Gel Blue® resin (Bio-
Rad, Hercules, CA). After loading to the column (2.5×5 cm) and a thorough wash
with the loading buffer, bound material was eluted with a linear gradient of NaCl(0–1.4 M) contained in 400 ml loading buffer supplemented with 1 mM each of
DTT and EDTA. The eluate was continuously monitored by absorbance at 280 nm
and was collected into 10 ml fractions. Fractions containing reductase activity were
pooled and concentrated by ultrafiltration to approximately 1 mg/ml. The purified
material was stored at 4 °C and used within 2 weeks or stored at − 70 °C.
Expression and purification of the Y55F mutant of AKR3A1 was carried out
exactly as for the wild type protein. Purification of the mutant protein was
monitored by the presence of a highly enriched ∼36 kDa protein band on SDS-
PAGE analysis of purification fractions. Materials extracted from induced
cultures of the E. coli strain BL21 host transformed with a nonrecombinant
(empty) pET expression plasmid were analyzed in a like manner.
2.3. AKR5F (Yjr096w)
Purification of recombinant AKR5F was achieved by anion exchange
chromatography using DEAE-Sepharose (Amersham Biosciences, Piscataway,
NJ). After overnight dialysis against 50 mM Tris–HCl, pH 8.0 containing 1 mM
EDTAand 1mMDTT, the cell-free extract was centrifuged briefly and the resulting
supernatant applied to a 2.5×10 cm column of the ion exchange chromatography
(IEC) resin. Bound proteins were eluted with a linear gradient of NaCl (0–0.4 M)
contained in 600 ml of equilibrating buffer. Presence of AKR5F in column
fractions was estimated by measuring NADPH-dependent reductase activity
using 2 mM p-nitrobenzaldehyde as the aldehyde substrate. Proteins in column
fractions were also visualized after separation by SDS-PAGE and Coomassie
staining. Fractions containing reductase activity were pooled, dialyzed into 10mM
potassium phosphate buffer, pH 7.0, and applied to a 2.5×5 cm chromatography
column packed with Affi-Gel Blue® (Bio-Rad) previously equilibrated with the
same buffer. After a wash to remove unadsorbed material, bound proteins were
eluted with a linear gradient of sodium chloride (0–2.5 M) contained in the
equilibration buffer. Reductase assays on column fractions identified an activity
peak that was coincident with a peak defined by A280. Fractions containing
reductase activity were pooled, concentrated to ∼1 mg/ml, and stored at 4 °C.
2.4. AKR5G (Ydl124w)
Preliminary studies showed that AKR5G expressed as a His-tagged fusion
protein had very lowAKR activity [16], data not shown]. In the present study, the
enzyme was expressed without an amino-terminal His-tag epitope. The majority
of recombinant AKR5Gwas found in the insoluble cell pellet following DNAse-
lysozyme extraction (not shown), and was recovered by treatment for 30 min at
4 °C with a cracking buffer consisting of 10 mM sodium phosphate, pH 7.2, 6 M
urea, 142 mM β-mercaptoethanol, and protease inhibitors essentially as
described previously [17]. Materials solubilized in cracking buffer were dialyzed
(Mr 12,000–14,000 cut-off tubing) against 100 volumes of DEAE column buffer
(10 mM Tris–HCl, pH 7.4, 0.5 mMDTT, 0.5 mMEDTA. After centrifugation to
remove insoluble materials, lysates were applied at 1 ml/min to a chromato-
graphy column (2.5×10 cm) packed with DEAE ion exchange resin previously
equilibrated with column buffer noted above. After flushing out unadsorbed
materials with a 500 ml buffer wash, bound proteins were eluted with a linear
gradient (0–200 mM) of sodium chloride prepared in column buffer. Eluate
fractions (10 ml) were assayed for the presence of NADPH-dependent aldo-keto
reductase activity using 5 mM DL-glyceraldehyde as a carbonyl substrate.
Fractions with reductase activity were pooled and further purified by dye affinity
chromatography essentially as described above for purification of AKR5F, with
the exception that boundmaterials were eluted first with a step increase from 0 to
1.5 M NaCl in the column buffer (200 ml) followed by a linear NaCl gradient
(1.5–2.5 M) contained in 300 ml column buffer. Fractions containing reductase
activity were pooled, dialyzed against 40 volumes of 10 mM potassium
phosphate, pH 7.2, containing 0.5 mM DTT and 0.5 mM EDTA. Purified
materials were stored at 4 °C for up to 2 weeks or for indefinite periods at − 70 °C.
2.5. Enzyme assays
Reductase activity was measured at 23 °C using a Cary 1E spectro-
photometer interfaced with a peltier temperature-controlling device. Assay
mixtures of 1.0 ml contained 0.15 mM NADPH and aldehyde substrate in a
triple buffer system consisting of 25 mM 2-(N-morpholino)ethanesulfonic acid,
Table 1
Strains used in this study
Strain Genotype Source
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Research
genetics
ARD10 BY4742 gre3Δ∷HIS3 ypr1Δ∷kanMX4 gcy1
∷URA3
This study
ARD11 BY4742 gre3Δ∷HIS3 ypr1Δ∷kanMX4 gcy1
∷URA3 ydl124wΔ∷LEU2
This study
ARD12 BY4742 gre3Δ∷HIS3 ypr1Δ∷kanMX4 gcy1
∷URA3 ydl124wΔ∷LEU2 yjr096wΔ∷bler
This study
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the pH optimum for the enzyme being tested (see below). Reactions were
initiated by addition of enzyme, and initial rates calculated from the decrease in
absorbance at 340 nm upon oxidation of NADPH. To determine steady state
kinetic constants, initial velocities observed as a function of substrate
concentration (ranging from approximately 0.1- to 5-times Km) were fitted to
the Michaelis–Menten equation using Graphpad Prizm (San Diego, CA).
2.6. Strains, gene deletion, and growth conditions
Parental wild-type yeast strain (BY4742) and isogenic single deletion
mutants, which were made available through the Yeast Deletion Project (ref
PMID: 12140549; see http://www.stanford.edu/group/yeastdeletionproject/
deletions3.html), were obtained from Research Genetics (Carlsbad, CA). A
list of yeast strains used in this study is summarized in Table 1. Generation of
AKR gene deletion mutants was performed by the PCR-mediated gene
disruption approach [18]. Targeting primers for disruption of open reading
frames used in conjunction with several different selectable markers carried in
the pRS4XX series of plasmids are shown in Table 2. PCR amplimers for
targeted gene disruption were used to transform recipient cells using the lithium
acetate method. After growth of transformants on selective media, deletion of
the targeted gene sequences was routinely confirmed by PCR using primer sets
directed toward sites internal as well as flanking the targeted gene of interest
(Table 3).
2.7. Cloning and mutagenesis of AKR3A1 (Gcy1) and AKR1B1
(human aldose reductase) for expression in yeast
While in the context of pBLUESCRIPT, codons for tyrosine-48 of AKR1B1
(human AR) [19], and the homologous site (tyrosine-55) of AKR3A1 (Gcy1),
were mutated to phenylalanine using a QuikChange site-directed mutagenesis
kit (Stratagene). For preparation of yeast expression constructs, the mutant genes
were released by endonuclease treatment (SpeI and HindIII for AKR1B1, and
BamHI and PstI for AKR3A1) and were ligated into the corresponding sites
of the episomal GPD425 expression vector as described above. DNA
sequencing across ligation sites and open reading frames was carried out to
confirm the fidelity of all plasmid constructs.Table 2
Oligonucleotides used for construction of deletion strains
Targeted Gene/ORF Primer sequence 5′ to 3′
GCY1 Sense: 5′ATATGCCTATCAGGCATTCACCCGTGTGAC
Anti-sense: 5′TGCCTTATACACCACCTATTCTGGCATC
YDL124W Sense 5′ACACATGTAAACGGTTGTGTTACCCTAAAG
ATGCAGCTGAAGCTTCGTACGC3′
Anti-sense: 5′AAGTCGATTAATAAAGTTATACAAAAC
AGCATAGGCCACTAGTGGATCTG3′
YJR096W Sense 5′ATATAAGAGCATAAGCAACTGATCTTACTTT
CAGCTGAAGCTTCGTACGC3′
Anti-sense 5′AAAAAGCTACATGTAATATTAATACTTT
TGCATAGGCCACTAGTGGATCTG3′3. Results
3.1. Characterization of yeast aldo-keto reductases
Yeast AKRs may be identified according to a gene name, an
ORF association, and according to a systematic AKR nomen-
clature [20]. A cross-referenced list of genes, ORFs, and AKR
designations is shown in Table 4. By BLAST search, we
previously identified six ORFs (YDR368W, YHR104W,
YOR120W, YBR149W, YJR096W, YDR124W) in the S. cere-
visiae genome sequence which showed clear amino acid
sequence similarity (30–44% identity) to human aldose
reductase (AKR1B1) [8]. Alignment of the deduced sequences
against the primary structure of human aldose reductase
indicates that amino acid side chains known to facilitate
catalysis in mammalian AKRs are strictly conserved across
these yeast proteins [19,21,22]. As a group, these proteins share
approximately 30–40% sequence identity, excepting AKR3A1
(Gcy1) and AKR3A2 (Ypr1), which are approximately 65%
identical. To evaluate the ability of the encoded proteins to
function as an NADPH-dependent aldo-keto reductase, ORFs
for putative AKRs were cloned into expression plasmids and
over-expressed in Escherichia coli host cultures. Studies of
AKR3C (Ara1) were not undertaken because, unlike AR, this
enzyme functions preferentially in the direction of NADP-
dependent aldose oxidation [12]. Various structural and kinetic
properties of some yeast AKRs examined in our study,
including, AKR3A2 (Ypr1) and AKR2B6 (Gre3), were reported
previously by us [8] and other investigators [9–11,23] using
recombinant and native enzymes purified from yeast cultures,
respectively. In the present work, we carried out a systematic
evaluation of the remaining putative AKRs including AKR5F
(Yjr096w), AKR5G (Ydl124w) and AKR3A1 (Gcy1) so as to
further our understanding of these proteins as functional aldo-
keto reductases.
Since only limited data was previously published on the
putative reductase activities of these putative AKRs [8,11,11,16],
we initiated a screen for aldo-keto reductase activity using
150 μM NADPH as cofactor and either DL-glyceraldehyde or p-
nitrobenzaldehyde as aldehyde substrate. These enzymes all
showed robust activity, with optima at pH 7.5–8.5 for AKR5F
and pH 6.0–7.5 for AKR3A1 (Fig. 2). Reductase activity for
AKR5G showed no distinct optimum over a pH range of pH 5Template
GAATCGCACA//AGATTGTACTGAGAGTGCAC3′ pRS406 (URA3)
TGCGGGATTTCG//CTGTGCGGTATTTCACACCG3′
AAACGGAGGTCAGTTAACAACACTTTTACAG pUG73(LEU2)
AAATATGACTCGTACATAAATTATCCGGTATTT
AGTAATTAACTTAGCATACCTAGCCCGAAGGA pUG66(bler)
GTGAAACGTAAACTAATTATATGTTCTATATACG
Fig. 1. pH Optima of yeast AKRs. Reductase activities were measured in a
1.0 ml assay solution containing enzyme, aldehyde substrate and 0.15 mM
NADPH in a triple buffer system titrated to the indicated pH values.
Table 3
Verification oligonucleotides
Gene/ORF Confirmation primers
YPR1 A: 5′-CATTCTCACTGATGCTATTGTC-3′
B: 5′-ATCAATGTGTCTGTATCCAGC-3′
C: 5′-ATGGCACTGTTGACATCG-3′
D: 5′-GATGACGACGGTCCGAA-3′
B' (HIS3): 5′-ACGCACTCTCACTACG-3′
C': (HIS3): 5′-CCTAGCGATAGAGCACT-3′
GRE3 A: 5′-CTCCTGGTACACTGAAGTAT-3′
B: 5′-TGAGACCTTCTTGATTACAT-3′
C: 5′-GTGCTTGCGACTACGG-3′
D: 5′-TCAACCATACAAGAGATGAA-3′
B': (KanMX) 5′-TGTACGGGCGACAGTCACAT-3′
C': (KanMX) 5′-CCTCGACATCATCTGCCCAGAT-3′
GCY1 A: 5′-CCTATCAGGCATTCACC-3′
B: 5′-GACGTGCCAGCTAATAAC-3′
C: 5′-ATGGCTACCGACACATTG-3′
D: 5′-CTTGCCTTATACACCACC-3′
B': (URA3) 5′-AGTTATCCTTGGATTTGG-3′
C': (URA3) 5′-ATCTCATGGATGATATCC-3′
YDL124W A: 5′-CGAAAGCGCGGAGAATTAA-3′
B: 5′-TGCCTTCCCAACTTCTGGATA-3′
C: 5′-TTGGTAGAAGCATACTCGCCA-3′
D: 5′-TAGCAACACATGATGCGCGT-3′
B': (LEU2) 5′-AGTTATCCTTGGATTTGG-3′ see ref. [42]
C': (LEU2) 5′-ATCTCATGGATGATATCC-3′ see ref. [42]
YJR096W A: 5′-TGAAGTAGTTATCATACATATTCCGTCG-3′
B: 5′-GAATCAAAAGAAGATCGATGTATTGC-3′
C: 5′-GGTCAACCAAATCGAGATATCACCT-3′
D: 5′-GGTAAGACTAGTAACGTCACATCGAAG-3′
B': (bler) 5′-GGATGTATGGGCTAAATG-3′ see ref. [42]
C': (bler) 5′-CCTCGACATCATCTGCCC-3′ see ref.[42]
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reductase activity level of each protein was not above background
when assays were conducted using DL-glyceraldehyde or p-
nitrobenzaldehyde as the aldehyde substrate and NADH instead
of NADPH. Using reaction conditions optimized for each
enzyme, catalytic constants were determined with a variety of
aldehyde substrates. As shown in Table 5, the catalytic efficiency
of AKR3A1 was generally higher than AKR5F or AKR5G with
almost all substrates examined. No measurable activity was
observed when each of these enzymes was assayed using aldose
substrates such as D-glucose and D-xylose. As a group, the
enzymes showed highest catalytic efficiencies with aromatic
aldehydes such as benzaldehydes and phenylglyoxal.Table 4
Aldo-keto reductases in Saccharyomyces cerevisiae
ORF Designation YHR104W YOR120W YDR368W
Gene Name GRE3 GCY1 YPR1
AKR Designation a AKR2B6 AKR3A1 AKR3A2
Reported Function Aldo-keto
reductase
Aldo-keto
reductase
Xylose
reductase
References [26,30,36,43] [27,30,41] [10,25]
a Nomenclature for the AKR Superfamily is available at http://www.med.upenn.eAlignment of amino acid sequences demonstrates that a
tyrosine at the position corresponding to tyrosine-48 in human
aldose reductase is conserved among all yeast AKRs examined
in this study [8]. We hypothesized that substitution of
phenylalanine for tyrosine-55 would result in loss of AKR
activity in AKR3A1 (Gcy1), similar to that observed with aldose
reductase [19] and 3α-hydroxysteroid dehydrogenase [24]. As
with wild type AKR3A1, the Y55F mutant was expressed toYBR149W YJR096W YDL124W
ARA1
AKR3C AKR5F AKR5G
Arabinose
Dehydrogenase
Xylose/arabinose
reductase
Xylose/arabinose
reductase
[12] [30] [30]
du/akr/.
Table 5
Kinetic constants for yeast aldo-keto reductases
AKR3A1 AKR5F AKR5G
Yor120w Yjr096w Ydl124w
Gcy1
DL-Glyceraldehyde
kcat (min
− 1) 539 6.6 4.1
Km (mM) 0.97±0.1 54±2 0.24±0.03
kcat/Km (min
− 1 mM− 1) 556 0.12 17
p-Nitrobenzaldehyde
kcat (min
− 1) 71 88 3.3
Km (mM) 0.13±0.002 0.5±0.06 0.03±0.004
kcat/Km (min
− 1 mM− 1) 546 176 110
Benzaldehyde
kcat (min
− 1) 58 4 4
Km (mM) 5.2±0.6 47±6 0.24±0.03
kcat/Km (min
− 1 mM− 1) 11 0.09 17
Phenylglyoxal
kcat (min
− 1) 111 2.4 985
Km (mM) 8.7±0.19 35±0.1 4.2±0.3
kcat/Km (min
− 1 mM− 1) 13 0.07 234
Acrolein
kcat (min
− 1) 30 1.0 3.4
Km (mM) 50±12.8 22±5.2 125±88
kcat/Km (min
− 1 mM− 1) 0.6 0.05 0.03
Butyraldehyde
kcat (min
− 1) 81 0.5 14
Km (mM) 54±2.8 18±8 210±145
kcat/Km (min
− 1 mM− 1) 1.5 0.03 0.07
D-glucose
kcat (min
− 1) NMA NMA NMA
D-Xylose
kcat (min
− 1) NMA NMA NMA
NADPH
kcat (min
− 1) 438 123 7.2
Km (mM) 0.012±0.003 0.37±0.1 0.023± .005
kcat/Km (min
− 1 mM− 1) 36500 332 313
Activity measurements with Yjr096w were performed at pH 8.0 and at pH 6.5
for Ydl124w and Gcy1. In all cases, NADPH was held constant at 0.15 mM.
Apparent Km and kcat values were determined by fitting initial rate data to a
general Michaelis–Menten equation using Graphpad Prizm (San Diego). For
each enzyme–substrate pair, n≥10. NMA, no measurable activity. Apparent
Km for NADPH was determined in the presence of fixed concentrations of
aldehyde substrate including 0.4 mM p-nitrobenzaldehyde for AKR3A1
(Yor120w), 2 mM p-nitrobenzaldehyde for AKR5F (Yjr096w), and 25 mM
phenylglyoxal for AKR5G (Ydl124w).
Fig. 2. Purification of AKR3A1 (Gcy1). Wild type (WT) and mutant (Y55F)
AKR3A1 were purified by dye-affinity chromatography using Affi-Gel Blue
(Bio-Rad). Column fractions were measured for protein by absorbance at 280 nm
(▪) and for NADPH-linked reductase activity using 5 mM DL-glyceraldehyde as
substrate (▾). Note 100-fold difference in scale on the ordinate axes showing
enzyme activities. (Inset: SDS-PAGE of material from the indicated column
fractions; WT, wild type AKR3A1).
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virtually homogeneous form by a two-step column purification
procedure. Although reductase activity in the Y55F mutant was
virtually undetectable, purification of the mutant was easily
followed by the appearance of a protein band of approximately
Mr 36000 on SDS-PAGE of material from column fractions (Fig.
2). High reductase activity levels were found in the correspond-
ing fractions from preparations startingwith wild type AKR3A1.
A protein band corresponding in size and abundance toAKR3A1 was not observed in whole cell extracts or in
purification fractions using material from induced E. coli
expression cultures transformed with an empty pET21d
expression plasmid (not shown).
Consistent with results from other aldo-keto reductases, the
substitution of Phe for Tyr-55 caused a dramatic reduction in
catalytic efficiency. Using DL-glyceraldehyde as a typical carbo-
nyl substrate, the catalytic efficiency of wild type AKR3A1 was
reduced from 553 mmol− 1 min− 1 to 0.16 mmol− 1 min− 1 for the
Y55F mutant. Virtually all of this change results from a reduction
in kcat, as there was a relatively small change in Km DL-
glyceraldehyde. The Km was 0.97±0.1 mM for wild type and
1.5±0.1 mM for the Y55F mutant.
3.2. Phenotypic characteristics of AKR deletion mutants
Based on this and previous work, it is clear that two of the
yeast AKRS examined, AKR5F (Yjr096w)and AKR5G
(Ydl124w), have a relatively poor ability to catalyze reduction
of carbonyls represented in our battery of substrates. Given that
AKR3A1 (Gcy1), AKR3A2 (Ypr1) and AKR2B6 (Gre3)
demonstrate more robust activity as aldo-keto reductases, we
hypothesized that these enzymes would be excellent candidates
to test for functional conservation with mammalian aldo-keto
reductases [8]. Accordingly, GCY1, YPR1, and GRE3 were
disrupted in a series of mutant strains to test the hypothesis that
326 Q. Chang et al. / Biochimica et Biophysica Acta 1773 (2007) 321–329human aldose reductase can functionally compensate for one or
more of the yeast AKR genes.
Single gene deletion mutants of YPR1, GRE3 or GCY1 do
not display an obvious phenotype [25–27]. This is not surprising
since these genes may be functionally redundant. We examined
double and triple AKR gene deletion mutants with a variety of
phenotypic screens including growth rate at normal (30 °C) or
elevated temperatures (37 °C) in YPD, cell morphology/budding
pattern, growth sensitivity to various stress inducible agents,
growth auxotrophy for different carbon sources and nutrients,
and growth sensitivity to screening drugs selected to probemajor
signaling transduction pathways and nucleic acid metabolism
(Table 6). In preliminary studies, we observed that mutants
missing any two of the three AKR genes were not distinguish-
able from the wild type strain, but deletion of all three AKR
genes (ypr1Δ/gre3Δ/gcy1Δ; strain ARD10) resulted in a
marked heat shock sensitivity [13]. In the current study, we
show that further disruption of ORFs that encode the two
additional putative AKRs resulted in an enhancement of the heat
shock phenotype (Fig. 3A).
Transformation of strain ARD10 with a plasmid carrying
GCY1, but not gcy1 Y55F, partially rescued the heat shock
sensitivity. (Fig. 3B). The human aldose reductase cDNA
expressed from the GPD promoter partially rescued heat shock
sensitivity, but not if it carried a mutation of the active site
tyrosine-48 residue (Y48F) to create a catalytically inactive
enzyme (Fig. 3B). These results indicate that either human or
yeast AKRs is capable of rescuing the heat shock phenotype in
triple AKR deficient mutant strains, suggesting some degree of
functional conservation among AKRs in yeast and humans.Table 6
Phenotypic screens for yeast AKR mutants
Phenotype Screening agent/parameter References
Heat shock Loss of viability following heat shock up to 55 °C [44,45]
Oxidative
stress
YPD+0.88 mM hydrogen peroxide [46,47]
YPD+1.5 mM diamide [48]
YPD+10 μM paraquat [49]
Osmotic stress YPD+1 M sorbitol
YPD+1 M NaCl
Temperature
sensitivity
Growth at 37 °C, YPD
Growth/
morphology
Growth rate (doubling time)
Viability (exclusion of propidium iodide)
Budding pattern (light microscopy)
Calcofluor sensitivity (YPD+0.1%
calcofluor)
[50]
Carbon
auxotrophy
YP+2% glucose
YP+2% galactose
YP+2% raffinose
YP+2% maltose
YP+2% sucrose
YP+3% glycerol
YP+2% potassium acetate
Nitrogen
starvation
Loss of growth on nitrogen-free medium [45]
Signal
transduction
YPD+10 mM caffeine [51]
YPD+0.1 μg/ml staurosporine [52]
Nucleic acid
metabolism
YPD+0.05% methyl methanesulfonate [53]
YPD+100 mM hydroxyurea [54]
YPD+60 μg/ml 6-azauracil [55]4. Discussion
The budding yeast Saccharomyces cerevisiae has six ORFs
that encode putative aldo-keto reductases (Table 4). Products of
YHR104W (Gre3) and YDR368W (Ypr1) were initially
identified as stress response proteins on the basis of their
upregulation following growth in the presence of hypertonic
media [26,28]. The product of YOR120W (Gcy1) was initially
identified as a galactose-inducible crystallin-like yeast protein
[27]. Subsequent studies demonstrated that each of these gene
products had properties typical of classical aldo-keto reductase,
i.e., catalytic activity with various classes of carbonyl-contain-
ing substrates, preferentially in the direction of carbonyl
reduction, using NADPH as the reducing coenzyme [9–11].
Current evidence suggests that YBR149W (Ara1) encodes a
dehydrogenase that functions preferentially in the direction of
arabinose oxidation rather than reduction [12]. The functions of
the remaining ORFs identified in our BLAST analysis,
including YDL124Wand YJR096W, have not been extensively
studied. Ishihara recently reported evidence that a yeast protein,
identical to that encoded by YDL124W, catalyzes the NADPH-
dependent reduction of aromatic α-keto amides and α-keto
esters [29]. Recent studies also indicate that the proteins
encoded by YJR096W and YDL124W and may play a role in
arabinose and xylose metabolism [30].
In preliminary studies, we showed that Gre3, Ypr1, Gcy1,
and human AR, purified as recombinant proteins, have
NADPH-dependent aldo-keto reductase activity using aldehyde
substrates such as DL-glyceraldehyde and p-nitrobenzaldehyde
[8]. This suggested to us that the functions of AKR genes
between yeasts and humans may be similar. Our observation
that ectopic expression of human aldose reductase rescues the
heat shock phenotype of the triple AKR null strain suggests that
human and yeast AKRs fulfill similar catalytic functions that are
necessary for recovery from stress associated with heat shock.
Since the catalytically-inactive mutants of human aldose
reductase or Gcy1 failed to show a rescue effect, it is possible
that the heat shock phenotype results from either an accumula-
tion of one or more unmetabolized AKR substrates or a
synthetic deficiency of AKR products generated in response to
stress or culture conditions. Further studies are ongoing to
identify pathways and processes that are influenced by the
action of AKRs.
Previous studies have shown that 4-hydroxynonenal (4-
HNE), a lipid-derived aldehyde produced during oxidative
stress, is a high affinity substrate for aldose reductase in
mammalian cells [31]. In addition, aldose reductase gene
expression is induced in response to osmotic stress [32,33].
Accordingly, we expected that deletion of the three cognate
AKR genes would induce phenotypes representative of
oxidative and osmotic stress. However, this is not the case, as
essentially no difference was observed in the growth of this
mutant when compared to wild type yeast under various
oxidative and osmotic stress conditions. We hypothesize that
this outcome may result from at least two possibilities. First,
lipid-derived reactive aldehydes, such as 4-HNE, are not
produced in yeast due to low amounts of polyunsaturated
Fig. 3. Heat shock phenotype of AKR mutant strains. After heat shock treatment, cell suspensions were serially diluted into water and spotted on selective plates
(-Leu). After incubation for ∼72 h at 30° , plates were imaged on a flat bed scanner to document recovery of growth. (A) Growth recovery following heat shock in the
wild type parental strain (BY4741) and isogenic strains containing 3 (ARD10), 4 (ARD11), and 5 (ARD12) disrupted AKR genes. Genotypes of relevant strains are
ARD10 (BY4742 gre3Δ∷HIS3 ypr1Δ∷kanMX4 gcy1∷URA3), ARD11 (BY4742 gre3Δ∷HIS3 ypr1Δ∷kanMX4 gcy1∷URA3 ydl124wΔ∷LEU2), and ARD12
(BY4742 gre3Δ∷HIS3 ypr1Δ∷kanMX4 gcy1∷URA3 ydl124wΔ∷LEU2 yjr096wΔ∷bler ). (B) Heat shock rescue experiments. Strains included the wild type
parental strain (BY4741), and the triple AKR null strain ARD10 (BY4742 gre3Δ∷HIS3 ypr1Δ∷kanMX4 gcy1∷URA3). Heat shock rescue experiments were carried
out by transforming strains BY4741 and ARD10 with expression plasmids encoding either human aldose reductase (HAR, AKR1B1) or Gcy1 (AKR3A1).
Dependence of phenotypic rescue on reductase activity was assessed by transforming heat shock sensitive strains with functionally inactive point mutants of human
aldose reductase (har) or Gcy1 (gcy1).
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by oxidative stress [34]. Although the heat shock phenotype
was glucose-dependent, we consider it unlikely that any of the
three disrupted AKRs play roles in the response to osmotic
stress through production of an osmolyte such as sorbitol.
Unlike human AR, none of the yeast AKRs are capable of
converting glucose to sorbitol, an active osmolyte known to be
involved in renal response to hypertonicity [35]. However, at
least two of the yeast AKRs, namely GRE3 and YPR1, were
identified as osmoregulated genes in previous studies [26,28].
Similar to findings reported here, previous investigators
observed no measurable difference from wild type control
when gre3 or ypr1 mutants were subjected to osmotic stress
[26,36].
Although AKR3A2 (Ypr1) and AKR2B6 (Gre3) have been
studied in the context of their activity as NADPH-dependent
carbonyl reductases, very little is known regarding the catalytic
activities of other yeast enzymes such as AKR3A1 (Gcy1),
AKR5F (Yjr096w) and AKR5G (Ydl124w). Our results
demonstrate each of these gene products has easily measured
activity as an NADPH-dependent aldehyde reductase. Human
and yeast AKRs appear to have similar activities when assayswere conducted with substrates such as aliphatic and aromatic
aldehydes. These results confirm that yeast, like mammalian
tissues, contain multiple AR-like enzymes with activity against
a broad range of aromatic and aliphatic aldehydes [37].
Crystallography studies of mammalian aldose reductases
indicate that the proteins adopt a (β/α)8 barrel structural fold
with the active site buried deep within the hydrophobic barrel
core. Functional and structural studies with human aldose
reductase (AKR1B1) suggest the importance of Asp-48, Lys-
77, Tyr-48 and His-110 as key residues in the catalytic sequence
[19,38,39]. Comparison with AKR1B1 shows that all of these
key residues are conserved at homologous sites throughout the
yeast AKRs. Similar to that observed with human aldose
reductase [19], mutagenesis of the presumptive hydrogen donor
to create the Y55F mutant of AKR3A1 (Gcy1) resulted in
essentially complete loss of AKR activity. Structural studies
have shown that, unlike the case with Tyr-48 in human aldose
reductase [19,40], the orientation of the Tyr-55 side chain is not
favorably positioned to function as an acid in the reduction
reaction [41]. Further study will be required to establish whether
AKR3A1 utilizes a different catalytic mechanism than hypo-
thesized for mammalian AKRs.
328 Q. Chang et al. / Biochimica et Biophysica Acta 1773 (2007) 321–329Since phenotypic abnormalities did not appear until ORFs
corresponding to at least three yeast AKRs were interrupted, we
hypothesize that these enzymes fulfill functionally redundant
roles even though their expression may fall under different
transcriptional control. Some differences were noted between
human and yeast enzymes with respect to catalytic efficiency
with some physiologically relevant substrates such as glucose.
However, the observation that human aldose reductase can
rescue the heat shock phenotype of the triple AKR null mutant
suggests that human and yeast AKRs share overlapping
physiological roles. Future studies will be needed to identify
pathways and structures that may be affected by deficiencies in
AKR gene expression in S cerevisiae. Such studies may provide
valuable clues in our ongoing studies to discover physiological
roles of this enzyme family in human tissues.
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